Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and reducing stress-induced hypermotility.
The value of CNS-specific eCOA provider in clinical trials – Pharmaceutical Technology
CNS assessments should be a consideration for all clinical trials, not just those that are CNS-based. Credit: ESB Professional via Shutterstock. The pharmaceutical industry is